2021 U.K. Molecular Diagnostics Market Assessment--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests--Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

The report is available by section, and can be customized to specific information needs and budget. The report presents analysis of the UK molecular diagnostics market, including:

  • Major issues pertaining to the UK molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Ten-year test volume and reagent sales forecasts for the following categories:

   -  Infectious Diseases

 

   -   Genetic Diseases

 

   -   Cancer

 

   -   Paternity Testing/HLA Typing

 

   -   Forensic Testing

 

  • Review of testing methodologies an instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.

Contains 1,122 pages and 53 tables This new 1,122-page report from LeadingMarketResearch.com contains 53 tables, and presents analysis of the UK molecular diagnostics market, including:

  • Major issues pertaining to the UK molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Ten-year test volume and reagent sales forecasts for the following categories:

   -  Infectious Diseases

 

   -   Genetic Diseases

 

   -   Cancer

 

   -   Paternity Testing/HLA Typing

 

   -   Forensic Testing

 

  • Review of testing methodologies an instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.

I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing
Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Market and Technology Review
A. DNA Sequencing
1. Introduction
2. Sequencing Methods
3. Autoradiography
4. The Human Genome Project
5. Sequencing Automation
Table of Contents (continued)
6. Image Scanners
7. Fluorescent Detection
8. Gene Profiling
9. Gene Expression
10. Polymorphism Screening
11. Protein Interaction Networks
B. DNA and RNA Probe Technologies
1. Basic Principles
2. Probe Preparation
3. The DNA Probe Test
4. Test Formats
5. Labeling Techniques
6. Amplification Methods
C. Detection Technologies
1. Radioactive Methods
2. Non-Isotopic Methods
D. Instrumentation
Review of latest analyzers from Abbott, Beckman Coulter/Danaher,
Becton Dickinson, bioMerieux, Bio-Rad, Cepheid, Hologic, Qiagen, Roche,
†Siemens Healthineers, and others.
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
F. Pharmacogenomics
G. Major Applications
1. Microbiology/Infectious Diseases
a. Overview
b. Major Infectious Diseases
° AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT,
Western Blot, HTLV-I/II
° Adenovirus
° Aeromonas
° Anthrax/Bacillus Anthracis
° Arboviruses
° Babesiosis
° Bacillary Epithelioid Angiomatosis (BEA)
and Other Bartonella (Rochalimaea)
° Blastocystis Hominis
° Brucella
° Campylobacter
° Candida
° Chagas Disease
° Chancroid
° Chlamydia
° Clostridium Difficile
° Coronaviruses
° Coxsackieviruses
° Creutzfeldt-Jakob’s Disease
° Cryptosporidium Parvum
° Cyclospora Cayetanensis
° Cytomegalovirus
° Ebola Virus
° E. Coli
° EchoVirus
° Encephalitis
° Enteroviruses
° Epstein-Barr Virus
° Giardia Lamblia
° Gonorrhea
° Granuloma Inguinale
° Hantavirus
° Helicobacter Pylori
° Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT,
Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
HBe Ag, ALT/SGPT
° Herpes Simplex Virus
° Human Herpes Virus-6 (HHV-6)
° Influenza Viruses
° Legionella
° Lyme Disease
° Lymphogranuloma Venereum (LGV)
° Malaria
° Measles (Rubeola)
° Meningitis
° Microsporidium
° Mononucleosis
° Mumps
° Mycoplasma
° Papillomaviruses
° Parvovirus B19
° Pneumonia
° Polyomaviruses
° Pseudomonas Aeruginosa
° Rabies
° Respiratory Syncytial Virus (RSV)
° Rhinoviruses
° Rotavirus
° Rubella
° Salmonellosis
° Septicemia
° Shigellosis
° Staphylococcus Aureus
° Streptococci
° Syphilis
° Toxoplasmosis
° Trichomonas Vaginalis
° Tuberculosis
° Vibrio
° West Nile Virus
° Yersina
2. Cancer Testing
a. Overview
b. Major Cancer Types
* Prostate
* Lung
* Colon and Rectum
* Breast
* Skin
* Uterine
* Leukemia
* Oral
c. Oncogenes
The report provides review of both current and emerging oncogenes, including:
O Abl/abl-bcr
O AIB1
Table of Contents (continued)
O BCL-2
O BRCA1
O CD44
O C-fos
O C-myb
O C-myc
O CYP17
O Erb-B
O HPC1
O N-myc
O P40
O P51
O P53
O PIK3CA
O PTI-1
O Ras
O Reg
O Sis
O Src
3. Genetic Diseases
a. Overview
b. Nucleic Acid Amplification
c. Chromosome Imaging
d. Genomics Technologies
e. Proteomics Technologies
f. Current Pharmacogenomic Tests
g. Future Pharmacogenomic Testing
h. Major Diseases
* Achondroplasia
* Autosomal Dominant Polycystic Kidney
Disease
* Cancer
* Cosmetogenomics
* Cystic Fibrosis
* Downs Syndrome
* Duchenne and Becker Muscular Dystrophy
* Factor V (Leiden)
* Factor IX Deficiency
* Fragile X Syndrome
Table of Contents (continued)
* Heart Disease
* Hemochomatosis
* Hemophilia
* Huntingtons Disease
* Maternal-Fetal Incompatibility
* Multiple Endocrine Neoplasia
* Phenylketonuria (PKU)
* Polycystic Kidney Disease (PKD)
* Prenatal Screening
* Retinitis Pigmentosa
* Retinoblastoma
* Sickle Cell Anemia
* Spinal Muscular Atrophy
* Vitamin B12 Metabolism
i. Social Issues and Concerns
4. Forensic Testing
a. Overview
b. Multilocus and Single Locus Probes
c. The FBI
d. DNA Profile Data Banks
e. Judicial Implementation
f. Major Crime Categories
g. Factors Contributing to the DNA Probe
Market Expansion
h. Wildlife Forensics
5. Paternity Testing/HLA Typing
6. Other Applications
a. Disease Susceptibility Testing
b. Cardiovascular Diseases
c. Diabetes
d. Alzheimers Disease
e. Periodontal Disease
f. Plasma Purification
g. Organ Transplantation
h. W ater Contamination
i. Other
Table of Contents (continued)
H. Competing/Complementing Technologies
1. Monoclonal Antibodies/Immunoassays
2. RNA Probes
3. Two-Dimensional Electrophoresis
4. Flow Cytometry
VII. Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts,
Major Supplier Sales and Market Shares
VIII. Competitive Assessments
The report provides strategic assessments of over 40 leading molecular diagnostics
market players and start-up companies with innovative technologies and products,
including:
Abbott, Agilent Technologies, Beckman Coulter/Danaher, Becton Dickinson,
bioMerieux, Bio-Rad, Cepheid, DiaSorin, Eiken Chemical, Enzo, Fujirebio, Grifols,
Hologic, Illumina, LabCorp/Sequenom, Leica Biosystems, Myriad Genetics, OrthoClinical Diagnostics, Qiagen, Quest Diagnostics, Quidel, Roche, Shimadzu,
Siemens Healthineers, Sierra Molecular, Takara Bio, Tecan Group, Thermo Fisher,
Wako and others.
Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct
Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct
Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular
Diagnostic Tests For Genetic Diseases
U.K.
Molecular Diagnostics Test Volume And Sales
By Major Application
U.K.
Laboratories Performing DNA Sequencing
By Market Segment
U.K.
Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment
U.K.
Molecular Diagnostics Test Volume
By Major Application
U.K.
Major Infectious Disease Test Volume by Assay
U.K.
Major Infectious Disease Test Volume by Method
U.K.
Molecular Diagnostics Market
By Major Application
U.K.
Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers
U.K.
Major Infectious Disease Diagnostics Market by Assay
U.K.
AIDS Testing Market
Estimated Sales by Major Supplier
U.K.
Gonorrhea Testing Market
Estimated Sales by Major Supplier
U.K.
Hepatitis Testing Market
Estimated Sales by Major Supplier
U.K.
Hepatitis C Testing Market
Estimated Sales by Major Supplier
U.K.
HIV/Hepatitis Blood Screening NAT Market
Reagent Sales by Major Supplier
U.K.
Influenza Testing Market
Estimated Sales by Major Supplier
U.K.
Mycoplasma Testing Market
Estimated Sales by Major Supplier
U.K.
Pneumonia Testing Market
Estimated Sales by Major Supplier
U.K.
Shigella Testing Market
Estimated Sales by Major Supplier Contains 1,122 pages and 53 tables


List Of Tables

Major Companies Developing or Marketing AIDS Molecular
 Diagnostic and Other Direct Identification Tests
 Major Companies Developing or Marketing Adenovirus
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Bartonella
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Campylobacter
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Candida
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Chlamydia
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Clostridium
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Coronavirus
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Cryptosporidium
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing CMV Molecular
 Diagnostic and Other Direct Identification Tests
 Major Companies Developing or Marketing Echovirus Molecular
 Diagnostic and Other Direct Identification Tests
 Major Companies Developing or Marketing Enterovirus Molecular
 Diagnostic and Other Direct Identification Tests
 Major Companies Developing or Marketing EBV Molecular
 Diagnostic and Other Direct Identification Tests
 Major Companies Developing or Marketing Giardia
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Gonorrhea
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Hantavirus
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Helicobacter
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Hepatitis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Herpes
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Influenza
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Legionella
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Lyme
 Disease Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Measles
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Meningitis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Mononucleosis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Mumps
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Mycoplasma
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Pneumonia
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing RSV
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Rotavirus
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Rubella
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Salmonella
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Septicemia
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Shigella
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Streptococci
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Syphilis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Toxoplasmosis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Trichomonas
 Molecular Diagnostic and Other Direct
 Identification Tests
 Major Companies Developing or Marketing Tuberculosis
 Molecular Diagnostic and Other Direct
 Identification Tests
 Oncogenes Potential Application in Cancer Diagnosis
 Major Companies Developing or Marketing Cancer
 Molecular Diagnostic Tests
 Major Companies Developing or Marketing Molecular
 Diagnostic Tests For Genetic Diseases
 U.K.
 Molecular Diagnostics Test Volume And Sales
 By Major Application
 U.K.
 Laboratories Performing DNA Sequencing
 By Market Segment
 U.K.
 Molecular Diagnostics Market
 Potential Laboratory Universe by Market Segment
 U.K.
 Molecular Diagnostics Test Volume
 By Major Application
 U.K.
 Major Infectious Disease Test Volume by Assay
 U.K.
 Major Infectious Disease Test Volume by Method
 U.K.
 Molecular Diagnostics Market
 By Major Application
 U.K.
 Molecular Diagnostics Market
 Estimated Sales And Market Shares of Major Suppliers
 U.K.
 Major Infectious Disease Diagnostics Market by Assay
 U.K.
 AIDS Testing Market
 Estimated Sales by Major Supplier
 U.K.
 Gonorrhea Testing Market
 Estimated Sales by Major Supplier
 U.K.
 Hepatitis Testing Market
 Estimated Sales by Major Supplier
 U.K.
 Hepatitis C Testing Market
 Estimated Sales by Major Supplier
 U.K.
 HIV/Hepatitis Blood Screening NAT Market
 Reagent Sales by Major Supplier
 U.K.
 Influenza Testing Market
 Estimated Sales by Major Supplier
 U.K.
 Mycoplasma Testing Market
 Estimated Sales by Major Supplier
 U.K.
 Pneumonia Testing Market
 Estimated Sales by Major Supplier
 U.K.
 Shigella Testing Market
 Estimated Sales by Major Supplier 


2021 Ecuador Tumor Markers Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 Ecuador Tumor Markers Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 3500

USD 3500 View Report

2021 Dominican Republic Tumor Markers Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 Dominican Republic Tumor Markers Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 3500

USD 3500 View Report

2021 U.K. Tumor Markers Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2021 U.K. Tumor Markers Market Assessment--Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines--Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers market research report available in single user pdf license with Aarkstore Enterprise at USD 4500

USD 4500 View Report

2021 U.K. Coagulation Testing Market Assessment--Chromogenic, Immunodiagnostic, Molecular Test Volume and Sales Segment Forecasts--Competitive Shares and Growth Strategies, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing

USD 4500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available